PEOPLE - Changes at Alaris Medical Systems (UK):
This article was originally published in Clinica
Executive Summary
Frederic Denerolle has been appointed vice-president and general of Alaris Medical Systems (Basingstoke, UK). Mr Denerolle succeeds Henk Van Rossem. Additionally, Sally Grigoriev has been named vice-president of operations. She replaces Joergen Lyngsgaard, who left the company on March 30. William Murphy, formerly director of regulatory affairs for Alaris, is named vice-president of regulatory affairs and quality assurance.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.